Russia was very likely involved in the production of smallpox as a biological weapon, as revealed in October 2020 findings from the Russian Leadership Initiative on relevant smallpox activity in Russian military laboratories.

According to the health secretary, Sajid Javid, there are now 20 cases in the UK, but “most cases” are minor. In addition to Central and West Africa, where the majority of prior cases have occurred, the virus has now been found in nine other nations.

Sickness outbreaks have recently occurred in 11 nations where the disease is uncommon.

Experts in Africa are baffled by its global spread. The Ministry of Defense and commercial lines have both been active in Africa, but no cases have been reported in Russia, despite the Russians’ substantial involvement there. As a result of the cessation of mass vaccination campaigns, no one is immune to smallpox any longer. Most countries lack immunizations since smallpox is believed to have been eradicated.

The employment of biological weapons by Moscow is not impossible, even if the Kremlin has drugs for a specific virus strain. In Ukraine, Russia claims to be engaged in a war with NATO, raising the possibility of using weapons of mass destruction.

Developing a smallpox therapy based on NIOCH-14 is a strategic priority for the Russians, according to our understanding. Russian military researchers studied the use of monkeypox as a bioweapon until at least the early 1990s.

Due to its greater virulence and devastation than COVID-19, smallpox poses a significantly greater threat to the stability of foreign regimes and could serve hostile aims such as upsetting the geopolitical landscape. The virus has been studied in Russia for the past ten years.

The Russian State Research Center for Virology and Biotechnology, VECTOR, has developed an automated kit for the detection of monkeypox virus positivity. The experiments in the lab went well. It was in 2021 that Ksenia Titova (Vector Center) presented her dissertation on “SCID mice as an animal model to test the efficiency of antismalpox drugs.”

Human-to-human transmission of monkeypox has been documented in international practice, but “vector” analyses imply a high probability of the disease spreading. A virus that the West does not know about may be eliminated by “Vector,” which can eliminate virulent mutant forms.

Smallpox viruses aren’t just being studied at ‘Vector,’ though. While working on the Ebola virus, the Ministry of Defense’s 48th Central Research Institute has been studying smallpox for a long time. 

In 2012, the 48 CRIs convened. Researchers: Borisevich, S.V., Marennikova, S.S., Makhlai, AA, Terentiev AA, Loginova SS Ya published ‘Monkeypox: Features of Spread After Cancellation of Mandatory Pox Immunization’ Following the eradication of smallpox and the suspension of the mandatory pox vaccine, the characteristics of monkeypox propagation were studied. Since the end of forced vaccinations, there has been a decrease in community pox immunity as well as a lack of awareness in the medical community about diseases caused by extra-hazardous human orthopoxviruses. 

As a result, human outbreaks caused by monkeypox can no longer be accurately predicted. If monkeypox outbreaks are to be contained, it will take widespread public education, the development of rapid diagnostic techniques, and the implementation of effective prevention measures.

Bioweapons based on viruses, rickettsia, and poisons were the primary focus of the 48th Research Institute (Zagorsky-6) during the Soviet Union. These generals, among others, were connected to the work of the Institute, including N.N. Vasiliev, D.V. Vinogradov-Volzhinsky, S.I. Prigod, A.A. Vorobyov, and V.A. Lebedinsky. A notable achievement of the Zagorsk-6 Institute is the ability to grow variola and Venezuelan equine encephalomyelitis viruses in chicken egg embryos. Ebola-fighting immunoglobulin was also created by the company. It was also worked on by Generals Klyuchari and Vorobyov on the virus genetics.

In addition to smallpox, monkeypox, Machupo, and Junin hemorrhagic fevers, the Zagorsk-6 Institute continues to work on pathogens that could be employed in biological weapons.

Smallpox strain “India-1” was discovered in 1967, which was the most virulent battle strain of the disease at the time. Researchers had been working on it since 1959, when Indian tourists brought smallpox to the USSR and returned with Soviet military microbiologists. In the end, Variola major was the prize of the voyage.

According to Kanatjan Alikbekov, who served as a First Deputy Director of the USSR Biological Weapons Development Agency, an Ebola-smallpox virus hybrid was being considered as a highly contagious biological weapon. A novel program was designed to choose “model” viruses instead of human smallpox, he explained.

Russia employed vaccinia, mousepox, rabbitpox, and monkeypox viruses as smallpox models. A primary goal was to do all the research and development on these viral models. It would only take two weeks to repeat the smallpox virus studies and stockpile the smallpox warfare agent once they obtained a set of positive results. A modified smallpox virus would be in Russia’s arsenal that might replace the current one. Consequently, Russia’s Ministry of Defense decided to keep working with monkeypox after the fall of the Soviet Union to “create future biological weapons.”

Cover-up strongly suggests that Russia is responsible for the spread of monkeypox.

U.S. researchers in Ukraine have been studying the EVD and smallpox viruses, according to Russian lawmaker Irina Yarovaya, who spoke out on the matter on May 21. In 2020, the Russian Ministry of Defense commissioned three institutes to look into this viral combo.

Ebola and smallpox were among the viruses and pathogens tested in the labs, in addition to those with an endemically close connection to Ukraine, according to her. Biological laboratories in Ukraine are one of Russia’s most important propaganda campaigns and information wars against the West. We believe that the Russians will use it as an excuse and explanation for continuing to develop biological weapons.

Leave a Reply

Your email address will not be published.